No Data
Enveric Biosciences Completes PK EB-003 Studies
Express News | Enveric Biosciences : Plans to Submit Eb-003 Ind Application to FDA in H2 of 2025
Express News | Enveric Biosciences Preclinical Pharmacokinetic Studies of Eb-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-Like Behavior
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
Express News | Enveric Biosciences Inc: On Nov 20, Nasdaq Issued Delisting Notice on Failing to Meet Minimum Bid Price Requirement
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
No Data
No Data
